|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Revenue | |||
| Cost of revenue | |||
| Gross profit | |||
| Operating expenses: | |||
| Selling and marketing | |||
| Research and development | |||
| General and administrative | |||
| Total operating expenses | |||
| Operating loss | |||
| Other income (expense): | |||
| Other (expense) income | |||
| Interest income | |||
| Interest expense | |||
| Total other income | |||
| Loss before income taxes | |||
| Provision for income taxes | |||
| Net loss | |||
| Comprehensive loss | |||
| Net loss per share attributable to Series A and Series B common stockholders, basic (in dollars per share) | |||
| Net loss per share attributable to Series A and Series B common stockholders, diluted (in dollars per share) | |||
| Weighted average common shares outstanding, basic (in shares) | |||
| Weighted average common shares outstanding, diluted (in shares) |
Loading...